Company Overview and News


Add CORI
to your dashboard

Headline News

Corium International's (CORI) CEO Peter Staple on Q4 2017 Results - Earnings Call Transcript

2017-11-17 seekingalpha
Good day, ladies and gentlemen and welcome to Corium International's Conference Call for its Fourth Fiscal Quarter and Year-End 2017. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] And as a reminder, this conference call maybe recorded. (24-0)

BRIEF-Corium reports Q4 loss per share $0.36

2017-11-16 reuters
* Corium International Inc - ‍Cash and cash equivalents as of September 30, 2017 were $57.5 million​ Source text for Eikon: Further company coverage: (8-0)

Your Daily Pharma Scoop: Progenics Looks Promising, Big Week For Dynavax, Keryx Ahead Of Catalyst

2017-11-06 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (692-3)

Bioscience Catalysts: Global Blood Therapeutics And Vanda Pharmaceuticals

2017-10-31 seekingalpha
The bioscience catalyst series seeks to help readers making sense of the notable life science runners. (61-1)

Insight From The Stellar Scientist Trader - An Integrated BioSci Investing Report

2017-10-25 seekingalpha
In the previous week, Dr. Tran BioSci of Integrated BioSci Investing had the honor to sit down with the expert, Decision Analytics in an interview. Our readers greatly benefited from his wisdom. His recommendation on Spectrum Pharmaceuticals (NASDAQ:SPPI) proved correct. The stock increased 36% the following day (and reached its 52-weeks high) after the accurate forecasting of the phase 2 trial (which studied poziotinib as a treatment for non small cell lung cancer with exon 20 mutation). (372-5)

Your Daily Pharma Scoop: Synergy's Cash Position, Flexion's Zilretta Approval, Keryx Major Catalyst

2017-10-10 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (963-5)

Biotech Forum Daily Digest: Still Gains Ahead For Dynavax?

2017-09-27 seekingalpha
We still have listless trading in the biotech sector while individual companies continue to implode or have rip roaring rallies triggered by company specific events. (127-1)

Corium International (CORI) Catches Eye: Stock Jumps 11.9%

2017-07-07 zacks
Corium International, Inc. (CORI - Free Report) was a big mover last session, as the company saw its shares rise almost 12% on the day. The move came  after will present clinical results from a bioequivalence study of Corium's once-weekly Corplex Donepezil product candidate at the Alzheimer's Association International Conference 2017 (AAIC) in London, UK. This led to far more shares changing hands than in a normal session.

Corium International: Room to Run?

2017-06-29 seekingalpha
I received an inquiry from a real-time follower yesterday around an "off the radar" concern that rarely comes up in conversation but it is a name I own a few shares in. Given it is selling right at the same level as it was when I did an exclusive "first look" piece for the Biotech Forum earlier this month, I thought I would republish that piece for today's analysis piece.

Amphastar (AMPH) in Focus: Stock Moves 9.7% Higher

2017-05-30 zacks
Amphastar Pharmaceuticals, Inc. (AMPH - Free Report) was a big mover last session, as the company saw its shares rise almost 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 11.9% in the past one-month time frame.

Finish Line Inc (FINL) and WashingtonFirst Bankshares Inc (WFBI) Lead 9 Investor Filings

2017-05-27 investorplace
There were nine notable investor filings over the past days, most notably Finish Line Inc (NASDAQ:FINL) as the largest company of interest.

BRIEF-Broadfin Capital reports passive stake of 12.74 pct in Corium International

2017-05-25 reuters
* Broadfin capital llc reports a passive stake of 12.74 percent in corium international as of may 25 - sec filing

AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session

2017-05-22 zacks
AxoGen, Inc. (AXGN - Free Report) was a big mover last session, as the company saw its shares rise a little above 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 26% in the past one-month time frame.

CUSIP: 21887L107